Table 4.
Significantly altered glycosaminoglycan biosynthesis enzymes in superficial injured compared to contralateral cortical tissue 7 days post-TBI. ** FDR p value < 0.01.
| Glycosaminoglycan Pathway | Gene Name | Gene Symbol | Function | Fold Change | FDR p-value |
|---|---|---|---|---|---|
| HS Biosynthesis | exostoses (multiple)-like 3 | Extl3 | Backbone elongation | −33% | 0.0037 |
| heparan sulfate 2-O-sulfotransferase 1 | Hs2st1 | 2-Sulfation | −29% | 0.0104 | |
| exostoses (multiple)-like 1 | Extl1 | Backbone elongation | −28% | 0.0208 | |
| exostoses (multiple)-like 2 | Extl2 | Backbone elongation | −25% | 0.0223 | |
| N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 | Ndst4 | N-sulfation | 490% | 0.0257 | |
| exostoses (multiple) 1 | Ext1 | Backbone elongation | −43% | 0.0262 | |
| CS + HS Biosynthesis | beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) | B3gat3 | Backbone elongation | −26% | 0.0241 |
| HA Biosynthesis | hyaluronan synthase 2 | Has2 | Elongation | 29% | 0.0264 |